Company

TauRx Pharmaceuticals Ltd

TauRx Pharmaceuticals develops treatments for neurodegenerative diseases such as Alzheimer's and frontotemporal dementia.

About

Founded in 2002 and headquartered in Aberdeen, UK, TauRx Pharmaceuticals Ltd develops treatments for neurodegenerative diseases, focusing on Alzheimer's disease and frontotemporal dementia, with its HMTM tablet under review by the MHRA. The company raised USD 119 mn on November 14, 2022, to speed product development and regulatory approvals, particularly in China. It is at the Series B stage and has completed 6 deals since inception.

2Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in